Ara 290 and Semaglutide Interaction
Ara 290 and Semaglutide have a compatible interaction with 90% confidence. No adverse interactions in clinical trials with GLP-1 agonists. These compounds primarily affect different organ systems.
Compound Profiles
Ara 290
Tissue-Protective Peptide | Innate Repair Receptor Agonist
Activates IRR through EPOR/β-common receptor complex, triggering tissue-protective signaling without erythropoietic effects..
View full profileSemaglutide
GLP-1 Receptor Agonist | Weight Loss & Diabetes
Mimics native GLP-1, binding to receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic pathways..
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Ara 290 with Semaglutide?
Yes, Ara 290 and Semaglutide can generally be taken together. No adverse interactions in clinical trials with GLP-1 agonists.
Is Ara 290 and Semaglutide safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between Ara 290 and Semaglutide?
No adverse interactions in clinical trials with GLP-1 agonists. This assessment has 90% confidence and is based on documented research data.
How should I time Ara 290 and Semaglutide?
Ara 290 has a half-life of ~20 minutes (SubQ), ~2 minutes (IV) and Semaglutide has a half-life of ~7 days (168 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.